Hertraz (150 mg, 440 mg)

Mylan

HERTRAZ contains Drugs / Molecule called “TRASTUZUMAB”. It is a monoclonal antibody that interferes with the HER/NEU receptor. The HER receptors are proteins that are embedded in the cell membrane and communicate molecular signals from outside the cell to inside the cell. It works by targeting certain tumour cells and stopping them from growing and reproducing.

Indication

Hertraz is used for the treatment of Metastatic Breast Cancer

Note

Precaution

  • Hertraz is a prescription drug and should be used under proper medical guidance and advice.
  • Hertraz should be avoided during pregnancy and lactation.